AN2 Therapeutics, Inc. - Common Stock (NQ:ANTX)

5.710 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AN2 Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2022 ↗

April 19, 2022

Upgrades

Via Benzinga

The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More ↗

April 17, 2022

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting...

Via Benzinga

RA Capital-Backed AN2 Therapeutics Hits NASDAQ, With IPO Price At $15 ↗

March 25, 2022

Via Benzinga

Opening Day: AN2 Therapeutics Rises In Public Debut After Upsized IPO ↗

March 26, 2022

Shares of AN2 Therapeutics rose over 15% in its trading debut on Friday following an upsized initial public offering. This was only the second initial public offering this month, as the IPO market...

Via Talk Markets

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO ↗

March 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Preview: An2 Therapeutics, Inc Set To IPO Tomorrow ↗

March 24, 2022

AN2 Therapeutics, Inc (NASDAQ:ANTX) IPO will take place March, 25 on the NASDAQ exchange under the ticker ANTX. The company is offering shares at an expected price between $14.00...

Via Benzinga

Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment

May 20, 2021

Via FinancialNewsMedia

Topics Death

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.